Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00354926 Information provided by Applied Molecular Evolution

First Received: July 18, 2006 Last Updated: June 3, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)